https://www.selleckchem.com/products/pr-619.html
Patients will be assigned at random to the COPD medical treatment + KT (Group 1), or the COPD medical treatment alone (Group 2). The outcome measures are pulmonary function and respiratory muscle strength. The level of statistical significance is set as P .05. This protocol will provide a reliable theoretical basis for the following research. It was hypothesized that thoracic KT could significantly change pulmonary function and functional capacity in patients with COPD. This study protocol was registered in Research Registry (resear
Like
Comment
Share
